Drug Profile
E 3030
Alternative Names: E3030Latest Information Update: 25 Jul 2007
Price :
$50
*
At a glance
- Originator Eisai Co Ltd
- Class Antihyperglycaemics; Antihyperlipidaemics
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 25 Jul 2007 Discontinued - Phase-I for Diabetes mellitus in Japan (unspecified route)
- 16 Sep 2004 Phase-I clinical trials in Diabetes mellitus in Japan (unspecified route)